Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pramipexole in Pediatric RLS
NCT02231918Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of pramipexole in restless legs syndrome (RLS) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration of the analyte in plasma at steady state at Day 1, Minimum measured concentration of the analyte in plasma at steady state at Day 1 and 2 more. Started May 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02231918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231918.